BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22767433)

  • 1. Has global fund support for civil society advocacy in the former Soviet Union established meaningful engagement or 'a lot of jabber about nothing'?
    Harmer A; Spicer N; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
    Health Policy Plan; 2013 May; 28(3):299-308. PubMed ID: 22767433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circus monkeys or change agents? Civil society advocacy for HIV/AIDS in adverse policy environments.
    Spicer N; Harmer A; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
    Soc Sci Med; 2011 Dec; 73(12):1748-55. PubMed ID: 22036298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'It's risky to walk in the city with syringes': understanding access to HIV/AIDS services for injecting drug users in the former Soviet Union countries of Ukraine and Kyrgyzstan.
    Spicer N; Bogdan D; Brugha R; Harmer A; Murzalieva G; Semigina T
    Global Health; 2011 Jul; 7():22. PubMed ID: 21752236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Civil society organisations and global health initiatives: problems of legitimacy.
    Doyle C; Patel P
    Soc Sci Med; 2008 May; 66(9):1928-38. PubMed ID: 18291566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
    McDonough A; Rodríguez DC
    Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of national and international HIV/AIDS funding and governance mechanisms on the development of civil-society responses to HIV/AIDS in East and Southern Africa.
    Kelly KJ; Birdsall K
    AIDS Care; 2010; 22 Suppl 2():1580-7. PubMed ID: 21161762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding role of civil society in the global HIV/AIDS response: what has the President's Emergency Program For AIDS Relief's role been?
    Coutinho A; Roxo U; Epino H; Muganzi A; Dorward E; Pick B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S152-7. PubMed ID: 22797737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials.
    Koen J; Essack Z; Slack C; Lindegger G; Newman PA
    Dev World Bioeth; 2013 Dec; 13(3):138-48. PubMed ID: 22998395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Virus Carriers' and HIV testing: navigating Ukraine's HIV policies and programming for female sex workers.
    Tokar A; Osborne J; Slobodianiuk K; Essink D; Lazarus JV; Broerse JEW
    Health Res Policy Syst; 2019 Feb; 17(1):23. PubMed ID: 30819203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical interactions between Global Fund-supported programmes and health systems: a case study in Papua New Guinea.
    Rudge JW; Phuanakoonon S; Nema KH; Mounier-Jack S; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i48-52. PubMed ID: 20966110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Civil society organizations: capacity to address the needs of the urban poor in Nairobi.
    Ekirapa A; Mgomella GS; Kyobutungi C
    J Public Health Policy; 2012 Nov; 33(4):404-22. PubMed ID: 22932021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. After the Global Fund: who can sustain the HIV/AIDS response in Peru and how?
    Amaya AB; Caceres CF; Spicer N; Balabanova D
    Glob Public Health; 2014; 9(1-2):176-97. PubMed ID: 24499125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Civil society organisations' roles in health development in Vietnam: HIV as a case study.
    Hoang TA
    Glob Public Health; 2013; 8 Suppl 1():S92-103. PubMed ID: 23822631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Civil Society Organizations in Monitoring the Global AIDS Response.
    Smith J; Mallouris C; Lee K; Alfvén T
    AIDS Behav; 2017 Jul; 21(Suppl 1):44-50. PubMed ID: 27734168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming governance or reinforcing hierarchies and competition: examining the public and hidden transcripts of the Global Fund and HIV in India.
    Kapilashrami A; McPake B
    Health Policy Plan; 2013 Sep; 28(6):626-35. PubMed ID: 23144229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical interactions between Global Fund-supported programmes and health systems: a case study in Thailand.
    Hanvoravongchai P; Warakamin B; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i53-57. PubMed ID: 20966111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing governance models and funding mechanisms of state-civil society partnerships for HIV/AIDS treatment and prevention based on lessons from Ghana.
    Hushie M
    Afr J AIDS Res; 2019 Jul; 18(2):138-147. PubMed ID: 31282299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.